Autor: |
Godara A; John Conant Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA, USA.; Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT, USA., Riesenburger RI; Department of Neurosurgery, Tufts Medical Center, Boston, MA, USA., Zhang DX; Department of Medicine, Tufts Medical Center, Boston, MA, USA., Varga C; John Conant Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA, USA., Fogaren T; John Conant Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA, USA., Siddiqui NS; John Conant Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA, USA.; Division of Hematology, Medical Oncology and Palliative Care, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA., Yu A; School of Medicine, Tufts University, Boston, MA, USA., Wang A; School of Medicine, Tufts University, Boston, MA, USA., Mastroianni M; School of Medicine, Tufts University, Boston, MA, USA., Dowd R; Department of Neurosurgery, Tufts Medical Center, Boston, MA, USA., Nail TJ; Department of Neurosurgery, Tufts Medical Center, Boston, MA, USA., McPhail ED; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Kurtin PJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Theis JD; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Toskic D; John Conant Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA, USA., Arkun K; Department of Pathology and Laboratory Medicine, Tufts Medical Center, Boston, MA, USA., Pilichowska M; Department of Pathology and Laboratory Medicine, Tufts Medical Center, Boston, MA, USA., Kryzanski J; Department of Neurosurgery, Tufts Medical Center, Boston, MA, USA., Patel AR; Division of Cardiology, Tufts Medical Center, Boston, MA, USA., Comenzo R; John Conant Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA, USA. |